Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong's Insilico Medicine, FT says

Sign up here. Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong's Insilico Medicine, FT says | Reuters Reuters could not immediately verify the report. Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv A drone view shows the Eli Lilly logo on one of the company's offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake Purchase Licensing Rights, opens new tab March 29 (Reuters) - Eli Lilly (LLY.N), opens new tabwill si ...